Nashita P. Patel

School Of Life Course Sciences
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7.

Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7.

Journal: British journal of cancer

Published: September 19, 2025

Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 08, 2025

Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Journal: Blood cancer journal

Published: June 12, 2024

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.

Journal: Cancer

Published: October 25, 2023

Treatment patterns and outcomes in patients with metastatic synovial sarcoma in France, Germany, Italy, Spain and the UK.

Treatment patterns and outcomes in patients with metastatic synovial sarcoma in France, Germany, Italy, Spain and the UK.

Journal: Future oncology (London, England)

Published: May 04, 2023

Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).

Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).

Journal: Future oncology (London, England)

Published: November 18, 2022

GLU: a software package for analysing continuously measured glucose levels in epidemiology.

GLU: a software package for analysing continuously measured glucose levels in epidemiology.

Journal: International journal of epidemiology

Published: December 13, 2019

The second generation of The Avon Longitudinal Study of Parents and Children (ALSPAC-G2): a cohort profile.

The second generation of The Avon Longitudinal Study of Parents and Children (ALSPAC-G2): a cohort profile.

Journal: Wellcome open research

Published: February 08, 2019

A Slow-Digesting, Low-Glycemic Load Nutritional Beverage Improves Glucose Tolerance in Obese Pregnant Women Without Gestational Diabetes.

A Slow-Digesting, Low-Glycemic Load Nutritional Beverage Improves Glucose Tolerance in Obese Pregnant Women Without Gestational Diabetes.

Journal: Diabetes technology & therapeutics

Published: September 12, 2018

Mode of infant feeding, eating behaviour and anthropometry in infants at 6-months of age born to obese women - a secondary analysis of the UPBEAT trial.

Mode of infant feeding, eating behaviour and anthropometry in infants at 6-months of age born to obese women - a secondary analysis of the UPBEAT trial.

Journal: BMC pregnancy and childbirth

Published: February 06, 2018

Gestational diabetes modifies the association between PlGF in early pregnancy and preeclampsia in women with obesity.

Gestational diabetes modifies the association between PlGF in early pregnancy and preeclampsia in women with obesity.

Journal: Pregnancy hypertension

Published: January 09, 2018

The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial.

The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial.

Journal: BMC medicine

Published: January 02, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026